AVE 0.00% 0.2¢ avecho biotechnology limited

current sp, page-93

  1. 5,322 Posts.
    A little competitive tension could deliver us a deal on OxyC Topical after Phase 2 results are in-and that could in turn trigger a deal for OxyM as I doubt these TPM Opioids will go to market on separate deals. 2014 is quite plausible for a license on TPM Pain Patches.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.